Intravenous Vitamin C (IVC)
Two time Nobel prize laureate, Linus Pauling is perhaps
more well know for his praise of natural therapies like vitamin C than his achievements in
chemistry. Pauling was vilified by the strongly anti-vitamin medical
establishment of the time.
In 1976 Linus Pauling and Ewan Cameron, MD
(surgical oncologist) published a
clinical trial in the prestigious Proceedings of the National Academy of
Sciences, in which 100 terminal cancer patients were treated with
intravenous vitamin C and compared with matched patients who did not receive
intravenous vitamin C.
The study showed an over 400% increase in mean survival
(50 vs 210 days).
Subsequently, two studies looking at vitamin C and cancer
were conducted at the Mayo clinic which showed no benefit. These
studies were touted by the mainstream medical establishment as proof that Cameron and Pauling's
findings were invalid.
However, these two negative trials used oral
vitamin C, rather than the intravenous protocol utilized by Cameron and Pauling. The obvious difference is that regardless of the amount of
vitamin C taken orally, blood levels can only reach a small fraction of
levels achieved with intravenous administration.
There are other critiques, however the difference
mentioned about is enough to cast serious doubt on the validity of those
subsequent negative trials.
Below are links to two very interesting articles on
high dose intravenous vitamin C (IVC) as a natural therapy for many kinds of cancer. The first contains both an intriguing experiment
and a number of fascinating case reports of cancer patients treated with
intravenous vitamin C. The second link is a small review article
looking at some of the published research on vitamin C and cancer.
Clinical And Experimental
Experiences With Intravenous Vitamin C.
Vitamin C As A Cancer
Treatment: State Of The Science And Recommendations For Research.
Medscape
Oncology report on the latest findings from Bastyr University's Integrative
Oncology study on Intravenous vitamin C and cancer.
